In fact, the founding members of the RAS gene family in humans (KRAS, NRAS and HRAS) are the most common oncogenes in human cancer, whereas mutations that permanently activate RAS are found in almost 25% of all human tumours and up to 90% in specific types of malignancies [31,32,33,34,35,36]. This evidence concerns the gene NRAS and cancer.